Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ABVC ABVC BioPharma
0.717-0.013-1.78%
Trading Session
01/31 11:48 ET
High
0.759
Open
0.746
Turnover
23.02K
Low
0.710
Pre Close
0.730
Volume
31.72K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Zacks Small Cap Weighs in on ABVC BioPharma, Inc.'s Q1 2023 Earnings (OTCMKTS:ABVC)
ABVC BioPharma, Inc. (OTCMKTS:ABVC – Get Rating) – Zacks Small Cap issued their Q1 2023 EPS estimates for ABVC BioPharma in a report issued on Wednesday, January 18th. Zacks Small Cap analyst M. M
ABVC BioPharma, Inc. (OTCMKTS:ABVC) Forecasted to Post Q1 2023 Earnings of ($0.05) Per Share
ABVC BioPharma, Inc. (OTCMKTS:ABVC – Get Rating) – Zacks Small Cap issued their Q1 2023 earnings estimates for ABVC BioPharma in a research report issued on Wednesday, January 18th. Zacks Small Ca
ABVC BioPharma Presents ABV-1505 ADHD Phase IIa Results
Watching ABVC BioPharma; Zacks Small-Cap Research Sets $2.02 Price Valuation
Watching ABVC BioPharma; Zacks Small-Cap Research Sets $2.02 Price Valuation
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersSpruce Biosciences (NASDAQ:SPRB) stock rose 80.0% to $2.25 during Friday's pre-market session. The market value of their outstanding shares is at $53.0 million. CytomX Therapeutics (NASDAQ:CTMX
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
Gainers OncoCyte Corporation (NASDAQ:OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products tha
Top Midday Gainers
01:45 PM EST, 01/05/2023 (MT Newswires) -- NovoCure (NVCR) and Zai Lab (ZLAB) said a study evaluating Tumor Treating Fields with standard therapies to treat stage 4 non-small cell lung cancer met its
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersBellerophon Therapeutics (NASDAQ:BLPH) stock rose 171.1% to $2.48 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 51.2 million shares, making up 2745
ABVC BioPharma Receives FDA Approval for New-Drug Application for Lung Cancer Treatment; Shares Skyrocket
09:58 AM EST, 01/05/2023 (MT Newswires) -- ABVC BioPharma (ABVC) shares were soaring more than 108% in early trading Thursday after the US Food & Drug Administration approved the company's investigati
Company Overview
More
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
CEO： Mr. Howard Doong
Market： NASDAQ
Listing Date： 08/03/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet